Found: 12
Select item for more details and to access through your institution.
Optimizing the use of CROs by academia and small companies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 487, doi. 10.1038/nrd4057
- By:
- Publication type:
- Article
AlzPED: Raising the Standards for Preclinical Efficacy Testing of Candidate Therapeutics in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074523
- By:
- Publication type:
- Article
Alzheimer's Disease Preclinical Efficacy Database (AlzPED): Optimizing the Scientific Rigor and Reproducibility of Preclinical Research in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.062566
- By:
- Publication type:
- Article
AlzPED: Optimizing the predictive power of drug efficacy studies in Alzheimer's disease animal models.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054045
- By:
- Publication type:
- Article
P4‐075: ALZPED: A NEW DATA RESOURCE FOR IMPROVING THE RIGOR, TRANSPARENCY, REPRODUCIBILITY AND TRANSLATION OF ALZHEIMER'S DISEASE PRECLINICAL RESEARCH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1303, doi. 10.1016/j.jalz.2019.06.3735
- By:
- Publication type:
- Article
International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 3, p. 405, doi. 10.1016/j.jalz.2013.12.013
- By:
- Publication type:
- Article
Common Alzheimer’s Disease Research Ontology: National Institute on Aging and Alzheimer’s Association Collaborative Project
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 4, p. 372, doi. 10.1016/j.jalz.2012.05.2115
- By:
- Publication type:
- Article
NIA Commentary: Translational Issues in Alzheimer's Disease Drug Development.
- Published in:
- Neuropsychopharmacology, 2012, v. 37, n. 1, p. 284, doi. 10.1038/npp.2011.116
- By:
- Publication type:
- Article
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies.
- Published in:
- Alzheimer's Research & Therapy, 2011, v. 3, n. 4, p. 90, doi. 10.1186/alzrt90
- By:
- Publication type:
- Article
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
- Published in:
- 2003
- By:
- Publication type:
- Correction Notice
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
- Published in:
- Journal of Neurochemistry, 2003, v. 85, n. 5, p. 1101, doi. 10.1046/j.1471-4159.2003.01654.x
- By:
- Publication type:
- Article
Targeting APP metabolism for the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 211, doi. 10.1002/ddr.10077
- By:
- Publication type:
- Article